Results 1 to 10 of about 772 (113)

Pigmented versus nonpigmented ocular surface squamous neoplasia: A comparative study of 424 tumors [PDF]

open access: yesTaiwan Journal of Ophthalmology
PURPOSE: The purpose of this study was to compare the clinical features, management, and outcomes of patients with pigmented ocular surface squamous neoplasia (p-OSSN) versus nonpigmented OSSN (np-OSSN).
Kavya Madhuri Bejjanki   +3 more
doaj   +2 more sources

Optimized Autofluorescence Spectral Signature for Non-Invasive Diagnostics of Ocular Surface Squamous Neoplasia (OSSN)

open access: yesIEEE Access, 2019
Clinical OSSN diagnostics by non-invasive spectral imaging of eye autofluorescence must be rapid enough to be comfortable for patients - without compromising accuracy.
Chandra Bala   +2 more
exaly   +3 more sources

Identification of dysregulated gene clusters and pathways driving ocular surface squamous neoplasia progression [PDF]

open access: yesScientific Reports
Ocular Surface Squamous Neoplasia (OSSN) represents a spectrum of ocular malignancies that threaten vision and ocular integrity. To unravel the molecular mechanisms underlying OSSN progression, we conducted RNA-sequencing on conjunctival tissues from ...
Kartik Goel   +10 more
doaj   +2 more sources

Ocular surface squamous neoplasia masquerades: Clinical profile and outcome [PDF]

open access: yesIndian Journal of Ophthalmology
Purpose: The diagnosis of ocular surface squamous neoplasia (OSSN) is primarily clinical, confirmed through histopathology, cytology, or imaging.
Shirali Gokharu   +3 more
doaj   +2 more sources

Oncological principles in the management of ocular surface squamous neoplasia - A Review [PDF]

open access: yesIndian Journal of Ophthalmology
Ocular surface squamous neoplasia (OSSN) is the most common neoplasia of the anterior segment. Accurate and timely diagnosis, including detailed clinical assessment and imaging, is essential to ascertain the extent of the disease.
Rolika Bansal, Santosh G Honavar
doaj   +2 more sources

Presumed reactivation of herpes simplex virus-associated endothelial keratitis after treatment with topical interferon-α 2b for ocular surface squamous neoplasia [PDF]

open access: yesBMC Ophthalmology
Background To report a case of herpes simplex virus (HSV)-associated endothelial keratitis in a patient receiving topical interferon (IFN)-α 2b for the management of ocular surface squamous neoplasia (OSSN).
Sepehr Feizi   +2 more
doaj   +2 more sources

Ocular Surface Squamous Neoplasia: A 12-Month Prospective Evaluation of Incidence in Waikato, New Zealand

open access: yesVision, 2022
Ocular surface squamous neoplasia (OSSN) has a high incidence in the southern hemisphere. This prospective study evaluated the incidence of OSSN in the Waikato region of New Zealand.
Ruhella R Hossain   +4 more
doaj   +1 more source

Ocular Surface Squamous Neoplasia (Ossn): A Retrospective Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Background: Ocular surface squamous neoplasia (OSSN) is a term used to describe neoplastic epithelial abnormalities of conjunctiva and cornea, ranging from Squamous Dysplasia to Invasive Squamous Cell Carcinoma. In recent times, the incidence of OSSN
PADMA PRABHA DANDALA   +2 more
doaj   +1 more source

Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia

open access: yesOman Journal of Ophthalmology, 2022
Ocular surface squamous neoplasia (OSSN) is the most common nonpigmented ocular surface neoplasm. Interferon-alpha (IFNα)-2b has been proved to be an effective immunotherapeutic agent to treat OSSN.
Murtuza Nuruddin   +2 more
doaj   +1 more source

Treatment of Navicular Stress Fracture Accompanied by Os Supranaviculare: A Case Report

open access: yesMedicina, 2021
Navicular stress fractures (NSFs) are relatively uncommon, and predominantly affect athletes. Patients complain of vague pain, bruising, and swelling in the dorsal aspect of the midfoot. Os supranaviculare (OSSN) is an accessory ossicle located above the
Woo-Jong Kim   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy